Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice

Pharmacology

Volumn 58, Issue 2, 1999, Pages 101-112

  Nagai, Hiroichi ^a   Matsuura, Satoko ^a   Bouda, Keiko ^a   Takaoka, Yuko ^a   Wang, Ting ^a   Niwa, Satoru ^a   Shudo, Koichi ^b  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Am 80; Collagen induced arthritis; IL 6; Retinoid

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COLLAGEN; COLLAGEN ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; RETINOID; TAMIBAROTENE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; DELAYED HYPERSENSITIVITY; FEMALE; FOOT PAD; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; AUTOANTIBODIES; BENZOATES; CELLS, CULTURED; COLLAGEN; CYTOKINES; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, INBRED DBA; PREDNISOLONE; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TETRAHYDRONAPHTHALENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032897495     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028272     Document Type: Article

References (31)

1. Kagechika H: Novel synthetic retinoid agonists and antagonists. Yakugaku Zasshi 1994;114:847-862.
2. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear recpetors. Nature 1987; 330:444-450.
3. Mangelsdorf DJ, Ong ES, Dick JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990;345: 224-229.
4. Carbe A, Buck J, Hämmerling U: Retinoids are important cofactors in T cell activation. J Exp Med 1992; 176:109-117.
5. Dennert G, Lotan R: Effects of retinoic acid on the immune system: Stimulation of T killer cell induction. Eur J Immunol 1978;8:23-29.
6. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skjfnsberg C, Blomhoff R: Vitamine A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem 1992;267:23988-23992.
7. Brinckerhoff CE, McMillan RM, Dayer JM, Harris ED Jr: Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells. N Engl J Med 1980;303:432-436.
8. Zhou Y, Mohan S, Linkhart TA, Baylink DJ, Strong DD: Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells. Endocrinology 1996;137:975-983.
9. Silverman AK., Ellis CN, Voorhees JJ: Hypervitaminosis A syndrome: A paradigmof retinoid side effects. J Am Acad Dermatol 1987;16:1027-1039.
10. Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, Karasuno K, Takeuchi M, Miyawaki S, Ueda R, Naoe T, Ohno R: New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: Clinical and basic studies for the next generation. Cancer Chemother Pharmacol 1997;40(suppl):S36-41.
11. Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, Karasuno T, Takeuchi M, Miyawaki S, Ueda R, Naoe T, Ohno R: Treatment with a new synthetic retinoid, Am-80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 1997;90:967-973.
12. Hashimoto Y, Kagechika H, Kawachi E, Shudo K: Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: Possibly the true retinoid receptor. Jpn J Cancer Res 1988;79:473-483.
13. Kagechika H, Kawachi E, Fukasawa H, Saito G, Iwanami N, Umemiya H, Hashimoto Y, Shudo K: Inhibition of IL-1-induced IL-6 production by synthetic retinoids. Biochem Biophys Res Commun 1997;231: 243-248.
14. Kuwabara K, Shudo K. Hori Y: Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEES Lett 1996;378: 153-156.
15. Koga T, Kakimoto K, Tanaka T, Hirofuji T, Sumiyoshi A: Clinicophathological features of collagen arthritis in the mouse. Ensho 1982;2:503-504.
16. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B: Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-668.
17. Trentham DE, Dynesius-Trentham RA: Attenuation of an adjuvant arthritis by type II collagen. J Immunol 1983;130:2689-2692.
18. Wooley PH, Luthra HS, Stuart JM, Davis CS: Type II collagen induced arthritis in mice. I Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
19. Stuart JM, Townes AS, Kang AH: Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673-683.
20. Panosian N, Heyner S, Capetola RJ, Orzechowski RF: Humoral and cellular immunologic aspects of adjuvant and collagen arthritis in rats. J Immunopharmacol 1986;8:347-370.
21. Stuart JM, Cremer MA, Townes AS, Kang AH: Type II collagen-induced arthritis in rats: Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982;155:1-16.
22. Hirofuji T, Kakimoto K, Hori H, Nagai Y, Saisho K, Sumiyoshi A, Koda T: Characterization of monoclonal antibody specific for human type II collagen: Possible implication in collagen-induced arthritis. Clin Exp Immunol 1985;62:159-166.
23. McCune WJ, Trentham DE, David JR: Gold does not alter the arthritic humoral or cellular responses in rats with type II collagen-induced arthritis. Arthritis Rheum 1980;23:932-936.
24. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H: T lymphocytes in collagen II-induced arthritis in mice: Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985;22:295-306.
25. Trentham DE, Dynesius RA, Davis JT Jr: Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest 1978;62:359-366.
26. Behlke MA, Chou HS, Huppi K, Loh DY: Murine T-cell receptor mutants with deletions of b-chain variable region genes. Proc Natl Acad Sci USA 1986;83:767-771.
27. Gerd RB, Stuhlmuller B, Keyszer G, Kinne W: Mononuclear phagocytes and rheumatoid synovitis: Master-mind or workhorse in arthritis? Arthritis Rheum 1997;40:5-18.
28. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 1996;85:307-310.
29. Houssian FA, Devogelar JP, Van Damme J, de Deuxchalnes CN, van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-788.
30. Wendling D, Racadot E, Wijdenes J: Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993; 20:259-262.
31. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G: Interleukin-6 is required for the development of collagen-induced arthritis. J Exp Med 1998;187:461-468.